A Pilot Study of 0.4% Povidone-Iodine Nasal Spray to Eradicate SARS-CoV-2 in the Nasopharynx

PURPOSE: This study aimed to evaluate the virucidal efficacy of 0.4% povidone-iodine (PVP-I) nasal spray against SARS-CoV-2 in the patients’ nasopharynx at 3 minutes and 4 hours after PVP-I exposure. PATIENTS AND METHODS: The study was an open-label, before and after design, single-arm pilot study o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirijatuphat, Rujipas, Leelarasamee, Amorn, Puangpet, Thanapat, Thitithanyanont, Arunee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790155/
https://www.ncbi.nlm.nih.gov/pubmed/36575672
http://dx.doi.org/10.2147/IDR.S391630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790155/
https://www.ncbi.nlm.nih.gov/pubmed/36575672
http://dx.doi.org/10.2147/IDR.S391630

Ejemplares similares